Affiliates Introduction
Establishing a foundation for excellent R&D infrastructure,
joint research network, and various raw materials businesses.
Development of special
enzymes/production strains
enzymes/production strains
Microbiome-Enzyme new drug
development
development
Special Enzyme & Bio-healthcare
raw material business.
raw material business.
- Fermentation technology using synthetic biology.
- Production of bio-healthcare materials.
- Acquired in March 2017 (formerly Sungwoon Bio)
- GF Fermentech(Sejong)
- Genome editing mediated production strain improvements.
- AI-based fermentation production optimization
- High-purity extraction/refinement and micro-formulations.
Food and medicine
ingredients.
Cosmetics material.
- Microbiome based
- New drug development and clinical trials control center
- Established on October 2018.
- Biologic (Seoul)
- Age-related Macular Degeneration (AMD)
- Uveitis, diabetic retinopathy (DME).
- Inflammatory bowel disease (IBD).
SOD-based new
synthetic
microbiome drug.
- Production of industrial enzymes, business development in China.
- Established on May 2012.
- Genofocus Biotechnology Inc. (Jiangsu, China)
- Mass production of industrial enzymes in China.
- Securing Chinese customers.
Supply to China semiconductor company.